Abdominal wall cellulitis in the morbidly obese

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 8, 2005, Pages 605-608

  Thorsteinsdottir, Bjorg ^a   Tleyjeh, Imad M ^a   Baddour, Larry M ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFAZOLIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DICLOXACILLIN; LEVOFLOXACIN; METICILLIN; METRONIDAZOLE; NAFCILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ABDOMINAL SURGERY; ABDOMINAL WALL; ADULT; AGED; BODY MASS; CELLULITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; FEMALE; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; MALE; MICROBIOLOGY; MORBID OBESITY; NONHUMAN; OUTPATIENT DEPARTMENT; RECURRENT INFECTION; RETROSPECTIVE STUDY; REVIEW;

ABDOMINAL WALL; ADULT; AGED; BODY MASS INDEX; CELLULITIS; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES; SYNDROME;

EID: 24644439226     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540510037957     Document Type: Review

References (18)

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents and adults, 1999-2002. JAMA 2004;291:2847-50.
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes and obesity related health risk factors, 2001. JAMA 2003;289: 76-9.
3. Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. Br Med J 1999;318:1591-4.
4. Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol 2002;100:959-64.
5. Baddour LM, Bisno AL. Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs. JAMA 1984;251:1049-52.
6. Swartz MN. Cellulitis. N Engl J Med 2004;350:904-12.
7. Baddour LM. Cellulitis syndromes: an update. Int J Antimicrob Agents 2000;14:113-6.
8. Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendation for the United States. Am J Clin Nutr 2000;72:1074-81.
9. Keys A, Fidanza F, Karvonen K, Chimaera N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis 1972;25: 329-43.
10. Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005; 142:47-55.
11. Hook EW 3rd, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986;146:295-7.
12. Ginsberg MB. Cellulitis: analysis of 101 cases and review of the literature. South Med J 1981;74:530-3.
13. Fleisher G, Ludwig S. Cellulitis: a prospective study. Ann Emerg Med 1980;9:246-9.
14. Bearden DT, Rodwold KA. Dosage adjustments for anti-bacterials in obese patients. Clin Pharmacokinet 2004;38: 415-26.
15. Madaras-Kelly KJ, Arbogast R, Jue S. Increased therapeutic failure for cephalexin versus comparator antibiotics in the treatment of outpatient cellulitis. Pharmacother 2000;20: 199-205.
16. Baddour LM, Bisno AL. Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise. Am J Med 1985;79:155-9.
17. Zackrisson G, Lind L, Roos K, Larsson P. Erythromycin-resistant beta-hemolytic streptococci group A in Goteborg, Sweden. Scand J Infect Dis 1988;20:419-20.
18. Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea. Anti-microb Agents Chemother 2004;48:2716-8.